Edwards Lifesciences Corp (EW)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$82.22

Buy

$84.00

arrow-down$-1.16 (-1.38%)

Prices updated at 13 Dec 2025, 00:17 EST

Prices minimum 15 mins delay

Prices in USD

Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	5,010m	5,440m
	4,032m	4,322m
	1,486m	1,480m
	29.66	27.21
	1,402m	4,175m
	1,535m	1,723m
Sales, General and administrative	1,583m	1,789m
Interest expenses	18m	20m
Provision for income taxes	152m	152m
Operating expenses	2,545m	2,842m
Income before taxes	1,372m	1,548m
Net income available to common shareholders	1,402m	4,175m
	2.31	6.98
Net interest income	50m	101m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	2.3	6.97
Free cash flow per share	1.2886	0.8122
Book value/share	11.0755	16.2175
Debt equity ratio	0.099579	0.067671

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	4,036m	6,285m
Current liabilities	1,195m	1,505m
Total capital	7,247m	10,596m
Total debt	695m	700m
Total equity	6,650m	9,998m
Total non current liabilities	-	-
Loans	597m	598m
Total assets	9,363m	13,055m
Total liabilities	-	-
Cash and cash equivalents	1,144m	3,045m
Common stock	601m	589m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	773m	1,148m
Cash dividends paid	-	-
	630m	260m
Investments (gains) losses	174m	2,313m
	1,148m	3,059m
Net income	-	-
	896m	542m
	-266m	-282m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.